Indeed, decreased PLN phosphorylation, leading to a decrease of Ca2+ uptake by SERCA2a, is a central feature of heart failure [80,81], and decreased inhibition of SERCA2a by PLN ablation can prevent progression of heart failure [82,83]. The gene discussed is PLN; the disease is heart failure.